Display options
Cite
Tvingsholm SA, Hansen MB, Clemmensen KKB, et al. Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1. Oncogenesis. 2018;7(2):14doi: 10.1038/s41389-017-0014-6.
Tvingsholm, S. A., Hansen, M. B., Clemmensen, K. K. B., Brix, D. M., Rafn, B., Frankel, L. B., Louhimo, R., Moreira, J., Hautaniemi, S., Gromova, I., Jäättelä, M., & Kallunki, T. (2018). Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1. Oncogenesis, 7(2), 14. https://doi.org/10.1038/s41389-017-0014-6
Tvingsholm, Siri Amanda, et al. "Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1." Oncogenesis vol. 7,2 (2018): 14. doi: https://doi.org/10.1038/s41389-017-0014-6
Tvingsholm SA, Hansen MB, Clemmensen KKB, Brix DM, Rafn B, Frankel LB, Louhimo R, Moreira J, Hautaniemi S, Gromova I, Jäättelä M, Kallunki T. Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1. Oncogenesis. 2018 Feb 03;7(2):14. doi: 10.1038/s41389-017-0014-6. PMID: 29396433; PMCID: PMC5833801.
Copy Download .nbib Format: NLM
Share it on

Oncogenesis. 2018 Feb 03;7(2):14. doi: 10.1038/s41389-017-0014-6.

Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1.

Oncogenesis

Siri Amanda Tvingsholm, Malene Bredahl Hansen, Knut Kristoffer Bundgaard Clemmensen, Ditte Marie Brix, Bo Rafn, Lisa B Frankel, Riku Louhimo, José Moreira, Sampsa Hautaniemi, Irina Gromova, Marja Jäättelä, Tuula Kallunki

Affiliations

  1. Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  2. Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
  3. Systems Biology Laboratory, Genome-Scale Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  4. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  5. Breast Cancer Biology, Genome Integrity Group, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
  6. Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark. [email protected].
  7. Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark. [email protected].

PMID: 29396433 PMCID: PMC5833801 DOI: 10.1038/s41389-017-0014-6

Abstract

Cancer cells utilize lysosomes for invasion and metastasis. Myeloid Zinc Finger1 (MZF1) is an ErbB2-responsive transcription factor that promotes invasion of breast cancer cells via upregulation of lysosomal cathepsins B and L. Here we identify let-7 microRNA, a well-known tumor suppressor in breast cancer, as a direct negative regulator of MZF1. Analysis of primary breast cancer tissues reveals a gradual upregulation of MZF1 from normal breast epithelium to invasive ductal carcinoma and a negative correlation between several let-7 family members and MZF1 mRNA, suggesting that the inverse regulatory relationship between let-7 and MZF1 may play a role in the development of invasive breast cancer. Furthermore, we show that MZF1 regulates lysosome trafficking in ErbB2-positive breast cancer cells. In line with this, MZF1 depletion or let-7 expression inhibits invasion-promoting anterograde trafficking of lysosomes and invasion of ErbB2-expressing MCF7 spheres. The results presented here link MZF1 and let-7 to lysosomal processes in ErbB2-positive breast cancer cells that in non-cancerous cells have primarily been connected to the transcription factor EB. Identifying MZF1 and let-7 as regulators of lysosome distribution in invasive breast cancer cells, uncouples cancer-associated, invasion-promoting lysosomal alterations from normal lysosomal functions and thus opens up new possibilities for the therapeutic targeting of cancer lysosomes.

References

  1. Mol Cancer Res. 2010 Feb;8(2):159-69 - PubMed
  2. Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53 - PubMed
  3. Science. 2008 Apr 4;320(5872):97-100 - PubMed
  4. Oncotarget. 2016 Sep 13;7(37):59845-59859 - PubMed
  5. Dev Cell. 2011 Sep 13;21(3):421-30 - PubMed
  6. Cell. 2005 Mar 11;120(5):635-47 - PubMed
  7. Trends Cell Biol. 2011 Apr;21(4):228-37 - PubMed
  8. Oncogene. 2015 Sep 10;34(37):4821-33 - PubMed
  9. Genes Dev. 2007 May 1;21(9):1025-30 - PubMed
  10. Oncol Lett. 2012 May;3(5):955-960 - PubMed
  11. Sci Signal. 2012 Jun 12;5(228):ra42 - PubMed
  12. Cancer Res. 1995 Aug 15;55(16):3610-4 - PubMed
  13. Cell. 2011 Nov 23;147(5):1066-79 - PubMed
  14. EMBO J. 2012 Mar 7;31(5):1095-108 - PubMed
  15. EMBO J. 2009 Feb 18;28(4):347-58 - PubMed
  16. Biochem Biophys Res Commun. 2006 Jan 6;339(1):217-25 - PubMed
  17. Oncogene. 2015 Mar 26;34(13):1641-9 - PubMed
  18. Chin J Physiol. 2012 Feb 29;55(1):31-6 - PubMed
  19. PLoS One. 2012;7(9):e45967 - PubMed
  20. Cancer Metastasis Rev. 2011 Jun;30(2):253-68 - PubMed
  21. Mol Cell. 2007 Jul 6;27(1):91-105 - PubMed
  22. Cancer Res. 2011 Oct 15;71(20):6463-74 - PubMed
  23. PLoS Biol. 2005 Mar;3(3):e85 - PubMed
  24. Cancer Res. 2004 Aug 1;64(15):5301-10 - PubMed
  25. PLoS One. 2013;8(1):e54213 - PubMed
  26. Oncogene. 2011 Jan 6;30(1):54-64 - PubMed
  27. Curr Oncol. 2010 Feb;17(1):70-80 - PubMed
  28. Cell. 2007 Dec 14;131(6):1109-23 - PubMed
  29. Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36 - PubMed
  30. Transl Res. 2011 Apr;157(4):216-25 - PubMed
  31. Genes Dev. 2009 Aug 1;23(15):1743-8 - PubMed
  32. Biomed Res Int. 2013;2013:868131 - PubMed
  33. J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):101-6 - PubMed
  34. Cell Cycle. 2007 Jan 1;6(1):60-4 - PubMed
  35. Cancer Cell. 2013 Sep 9;24(3):379-93 - PubMed
  36. Mol Cell Proteomics. 2013 Feb;12(2):381-94 - PubMed
  37. Mol Oncol. 2014 Dec;8(8):1703-18 - PubMed
  38. Mol Cell. 2012 Mar 30;45(6):764-76 - PubMed
  39. Oncogene. 1995 Jan 5;10(1):167-75 - PubMed
  40. Nat Rev Cancer. 2015 Dec;15(12):712-29 - PubMed
  41. Oncogene. 2013 Apr 18;32(16):1995-2004 - PubMed
  42. Cell Cycle. 2012 Jul 1;11(13):2415-6 - PubMed
  43. Nucleic Acids Res. 2001 May 1;29(9):e45 - PubMed
  44. Biochim Biophys Acta. 2014 Aug;1840(8):2560-70 - PubMed
  45. Mol Cell Proteomics. 2015 Aug;14(8):2213-28 - PubMed
  46. Nat Rev Mol Cell Biol. 2009 Sep;10(9):623-35 - PubMed
  47. PLoS One. 2015 May 26;10(5):e0127420 - PubMed
  48. Genes Dev. 2006 Mar 1;20(5):543-56 - PubMed
  49. Cancer Genomics Proteomics. 2010 Sep-Oct;7(5):261-77 - PubMed
  50. J Biol Chem. 1991 Aug 5;266(22):14183-7 - PubMed
  51. Int J Oncol. 2015;46(6):2526-34 - PubMed
  52. Science. 2011 Jun 17;332(6036):1429-33 - PubMed
  53. Cancer Res. 2005 Aug 15;65(16):7065-70 - PubMed
  54. Curr Opin Cell Biol. 2016 Apr;39:69-76 - PubMed
  55. EMBO J. 2011 Aug 26;30(21):4500-14 - PubMed
  56. J Biol Chem. 2007 Feb 9;282(6):4045-56 - PubMed
  57. Chin J Physiol. 2007 Feb 28;50(1):9-15 - PubMed
  58. Cancer Res. 2006 May 15;66(10):5242-50 - PubMed
  59. Int J Cancer. 2001 Oct 15;94(2):185-91 - PubMed
  60. J Biomol Screen. 2006 Dec;11(8):922-32 - PubMed

Publication Types

Grant support